943976-22-5Relevant articles and documents
Synthesis and evaluation of mefway analogs as ligands for serotonin 5HT1A receptors
Thio, Joanne P.,Liang, Christopher,Bajwa, Alisha K.,Wooten, Dustin W.,Christian, Bradley T.,Mukherjee, Jogeshwar
, p. 1480 - 1486 (2015/04/27)
18F-Mefway (N-{2-[4-(2′methoxyphenyl)piperazinyl]ethyl}-N-(2-pyridyl)-N-(4′18F-fluoro-methylcyclohexane)carboxamide) was developed and evaluated for use as a PET ligand for imaging 5-HT1A receptors. Ongoing studies of sup
NOVEL SYNTHESIS METHOD
-
, (2013/04/10)
The present invention relates to a method of making compounds having affinity for the 1 A subtype of the serotonin receptor, i.e. 5HT1A. The method of the present invention provides advantages over the known methods of synthesis. The compounds
5HT1A ANTAGONIST USEFUL FOR IN VIVO IMAGING
-
, (2013/03/26)
The present invention provides a novel compound of formula (I) useful for in vivo imaging of 5-HT1 A receptors in a subject. Also provided by the present invention is a precursor compound useful in the preparation of the compound of the inventi
COMPOSITIONS AND METHODS RELATED TO SEROTONIN 5-HT1A RECEPTORS
-
Page/Page column 7-8, (2008/06/13)
Contemplated substituted arylpiperazinyl compounds, and most preferably 18F-Mefway, exhibit desirable in vitro and in vivo binding characteristics to the 5-HT1A receptor. Among other advantageous parameters, contemplated compounds retain high b